News
16h
Zacks Investment Research on MSNEli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no ...
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Merck MRK recently intensified its acquisition strategy, actively pursuing deals to enhance its development pipeline and ...
But since Tuesday, when Donald Trump said in a cabinet meeting that imported pharmaceuticals would face a massive levy, ...
6d
Live Science on MSNExperimental treatment for high cholesterol edits DNA in the body to reduce LDLAn experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" ...
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results